In @ScienceMagazine this week, @BaranLabReads expands the generality of their P(V) platform for selective oligonucleotide synthesis https://t.co/r6WFNajImM
It’s a P(V) world and we’re just living it in. The fully P(V) approach from #bmschemistry gave 5.8 x yield of these otherwise challenging molecules and enabled toxicology delivery! https://t.co/QUgM3fQkPQ
@BaranLabReads If you don’t want to wait for @elonmusk just come to Mauna Kea summit, little oxygen, reddish earth and freezing temperatures. Should name it the almost Mars experience.
In 2016, with @EastgateMartin and the @bmsnews team we set out to simplify the way Oligonucleotides therapeutics (OTs) are made. Access to a 3-10-3 LNA/DNA gapmer with 4 different P-linkages had pushed the limits of known chem. Today we report a solution: https://t.co/hSsZXFg3DJ
Modify DNA as if it were a simple alcohol derivative: Possible now with SENDR, appearing today in @ACSCentSci : https://t.co/XK6v0U1Gr2 For a behind-the-scenes look at SENDR and bioconjugation, visit Open Flask: https://t.co/HvffswyQce
@elonmusk how long before we can expect the “Lab-on-a-Tesla”? Autonomous, contact free, testing robot that can be deployed to hotspots? Context: https://t.co/0oDxbRdvxT